H
Hongwei Pan
Researcher at Hunan Normal University
Publications - 2
Citations - 95
Hongwei Pan is an academic researcher from Hunan Normal University. The author has contributed to research in topics: Clinical endpoint & Occlusion. The author has an hindex of 1, co-authored 2 publications receiving 2 citations.
Papers
More filters
Journal ArticleDOI
Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial.
Bo Xu,Shengxian Tu,Lei Song,Zening Jin,Bo Yu,Guosheng Fu,Yujie Zhou,Jian-an Wang,Yundai Chen,Jun Pu,Lianglong Chen,Xinkai Qu,Junqing Yang,Xuebo Liu,Lijun Guo,Chengxing Shen,Yao-Jun Zhang,Qi Zhang,Hongwei Pan,Xiaogang Fu,Jian K. Liu,Yanyan Zhao,Javier Escaned,Yang Wang,William F Fearon,Kefei Dou,Ajay J. Kirtane,Yongjian Wu,Patrick W. Serruys,Weixian Yang,William Wijns,Changdong Guan,Martin B. Leon,Shubin Qiao,Gregg W. Stone +34 more
TL;DR: The FAVOR III China trial as mentioned in this paper showed that a QFR-guided strategy of lesion selection for percutaneous coronary intervention improved 1-year clinical outcomes compared with standard angiography guidance.
Journal ArticleDOI
Active SB-P Versus Conventional Approach to the Protection of High-Risk Side Branches: The CIT-RESOLVE Trial
Kefei Dou,Dong Zhang,Hongwei Pan,Ning Guo,Lang Li,Yue Li,Qi Zhang,Bin Liu,Zhujun Shen,Bin Zhang,Jian K. Liu,Wei Han,Yang Wang,Yanyan Zhao,Yuejin Yang,Shao-Liang Chen,Lihua Xie,Changdong Guan,Ajay J. Kirtane,Bo Xu +19 more
TL;DR: An active SB-P strategy is superior to a conventional strategy in reducing SB occlusion when treating high-risk bifurcation lesions.